Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

July 12, 2017 by Alan Khadavi

Criteria for Dupixent (dupilumab) for Eczema

criteria for dupixent (dupilumab)

There is no set criteria for dupixent (dupilumab), but there are guidelines in place that Regeneron and Sanofi recommend to get patients enrolled through their insurance companies.  Every insurance company has their own criteria, but under Regeneron and Sanofi’s, Dupixent My Way, they set out guidelines which would help get approval easier for Dupixent. Being a very […]

Filed Under: atopic dermatitis, Blog

July 10, 2017 by Alan Khadavi

Do you really have a Penicillin Allergy?

penicillin allergy

Penicillin allergy is reported by approximately 7-10% of the population, penicillin allergy is one of the most common medication allergies.  Having a penicillin allergy places a significant impact on health related costs and outcomes.  Studies have shown that 90% of individuals reporting penicillin allergy are not found allergic after appropriate evaluation.  Many patients have been […]

Filed Under: Allergy Testing, Blog, drug allergy

June 28, 2017 by Alan Khadavi

Symjepi a cheaper alternative to Epipen, FDA Approved

symjepi

Symjepi was recently approved by the FDA that will directly compete with other injectable epinephrine medications.  Symjepi will be manufactured by Adamis Pharamceuticals Corporation.  Symjepi will come as 2 single dose syringes of 0.3 milligrams of epinephrine, a life saving medication for those allergic to bee stings, food allergies, medication allergies or anyone suffering from […]

Filed Under: Anaphylaxis, Blog

June 21, 2017 by Alan Khadavi

NHL Hockey Star, Marian Hossa Retiring Because of Allergy

Marian Hossa, an NHL winger for the Chicago Blackhawks will miss the upcoming season due to an allergy reaction to his hockey equipment.  He has stated that he has developed severe side effects from the medication to treat his skin disorder.  “While I am disappointed that I will not be able to play, I have […]

Filed Under: Blog, Headlines

June 15, 2017 by Alan Khadavi

How to Prevent Eczema in Children

prevent eczema

In order to prevent eczema children, we first need to discuss atopic dermatitis (eczema) first.  Atopic dermatitis affects 17-24% of the pediatric population and 4-7% of adults.  It develops in the first 6 months in about half the children and by 5 years of age in 85% of the cases.  Only about half of affected […]

Filed Under: atopic dermatitis, Blog, Pediatric

June 6, 2017 by Alan Khadavi

Trimbow Triple Combination For COPD and Asthma by Chiesi

Explore how camlipixant, a selective P2X3 antagonist, reduces cough frequency and improves quality of life in patients with refractory chronic cough.

Trimbow a fixed combination triple therapy for COPD, recently received a positive opinion from the FDA of Europe, Committee for Medicinal Products for Human Use (CHMP).  Trimbow combines three ingredients, an Inhaled Corticosteroid (ICS) / Long-acting β2-agonist (LABA) / long-acting muscarinic antagonist (LAMA) that contains Beclometasone dipropionate (BDP), Formoterol fumarate (FF) and Glycopyrronium bromide (GB). In […]

Filed Under: Asthma, Blog

May 30, 2017 by Alan Khadavi

Trelegy, New Asthma Triple Therapy to be Released by GSK

Itepekimab and Brodalumab

Trelegy, a new asthma medication by GlaxoSmithKline (GSK) is currently being developed for the treatment of asthma and COPD.  Trelegy will consist of 3 medications, fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI).  The ingredients are an inhaled steroid, a long acting muscaranic antagonist and a long acting beta-agonist.  The medication will be delivered once daily as a dry powder inhaler. […]

Filed Under: Asthma, Blog

May 24, 2017 by Alan Khadavi

Allergy Biologics, Past, Present and Future…

allergy biologics

The world of allergy biologics has exploded in the last year.  New biologic agents are being developed that target specific and critical pathways to help manage patients who have asthma, hives, eczema and nasal polyps.  Here I will focus on allergy biologics already approved for management of asthma and allergies as well as allergy biologics […]

Filed Under: Asthma, Blog, Medications

May 12, 2017 by Alan Khadavi

How does Autism affect Asthma?

autism and asthma

Autism and asthma are among the most common chronic diseases in childhood.  Both conditions typically present in early childhood and involve altered immune regulation.  There has been an increase in asthma and autism prevalence that has not been conclusively explained.  They share similar risk factors including prematurity, low birth weight, urban environment and firstborn birth […]

Filed Under: Asthma, Blog

May 9, 2017 by Alan Khadavi

Natural Sinus Tips for Sinus Headaches

sinus headaches

Sinus headaches can cause a pounding headache.  A feeling of a stuffed-up head and post nasal drip.  Sinus pain can be worsened during the allergy season as germs and mucus make their way into your sinus cavities. When an allergy, cold or flu causes tissues to swell and fill with mucus, the tiny hairs inside […]

Filed Under: Blog, Sinus

  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 57
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page